Literature DB >> 23138610

Excimer laser atherectomy after unsuccessful angioplasty of TASC C and D lesions in femoropopliteal arteries.

C Wissgott1, P Kamusella, C Lüdtke, R Andresen.   

Abstract

AIM: The study objective was to examine the application of excimer laser atherectomy (ELA) in patients with refractory occlusions in femoropopliteal arteries, where the initial conventional percutaneous transluminal angioplasty (PTA) recanalization attempts, were unsuccessful.
METHODS: The average age of the 40 patients (32 men, 8 women) included in this study was 65.4±9.1 years. The average occlusion length was 17.5 cm (range: 12-25 cm). The initial recanalization attempts were performed with stiff Terumo guidewires (curved or straight) supported by various catheters (straight/multipurpose/Cobra). After the unsuccessful attempt, an excimer laser catheter (catheter diameters from 1.7-2.5 mm) was used for recanalization using the step-by-step method of crossing. After successful crossing, balloon dilatation was performed in all cases. Stent implant was required in 10% (4/40) of procedures. Patients were followed for 12 months with colour-coded Duplex sonography (CCDS).
RESULTS: The initial technical success rate of 90% (36/40) resulted in primary, primary-assisted and secondary-assisted patency rates of 58.9%, 67.8% and 83.2%, respectively, after 12 months. No serious complications occurred that were attributable to the intervention.
CONCLUSION: According to these results, ELA recanalization provides a low stent rate alternative to surgical procedures for refractory occlusions. This would offer patients, with increased operative risks, a promising and low-risk therapeutic procedure. The option of a subsequent vascular operation would not be compromised.

Entities:  

Mesh:

Year:  2012        PMID: 23138610

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  4 in total

1.  Excimer laser ablation combined with drug-coated balloon versus drug-coated balloon in the treatment of de novo atherosclerotic lesions in lower extremities (ELABORATE): study protocol for a real-world clinical trial.

Authors:  Xiaolang Jiang; Longhua Fan; Bin Chen; Junhao Jiang; Jianjun Liu; Guanyu Qiao; Shuai Ju; Yun Shi; Tao Ma; Changpo Lin; Gang Fang; Daqiao Guo; Xin Xu; Zhihui Dong; Weiguo Fu
Journal:  BMC Cardiovasc Disord       Date:  2022-07-16       Impact factor: 2.174

2.  Transpopliteal balloon-assisted excimer-laser atherectomy for the treatment of chronic femoropopliteal occlusions: feasibility and initial results.

Authors:  Christopher W Lüdtke; Fabian Scheer; Peter Kamusella; Christian Wissgott; Reimer Andresen
Journal:  Clin Med Insights Cardiol       Date:  2015-02-24

3.  Combination of rotational atherothrombectomy and Paclitaxel-coated angioplasty for femoropopliteal occlusion.

Authors:  F Scheer; C W Lüdtke; P Kamusella; P Wiggermann; H Vieweg; E Schlöricke; M Lichtenberg; R Andresen; C Wissgott
Journal:  Clin Med Insights Cardiol       Date:  2015-04-21

4.  Excimer laser atherectomy combined with drug-coated balloon angioplasty for the treatment of chronic obstructive femoropopliteal arterial disease.

Authors:  Hui Liu; Yan Gu; Sen Yang; Ju He; Fuxian Zhang
Journal:  Exp Ther Med       Date:  2019-12-20       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.